Objective: This study aimed to determine the prevalence of polypharmacy and its associated factors in older adults living in rural areas. Material and Methods: This cross-sectional study included a total of 585 older adults aged ≥65 years living in a town in western Türkiye. Data were collected through face-to-face interviews at family health centers using a questionnaire prepared by the authors in line with the literature. The data collected for the research were analyzed using the SPSS for Windows 25.0. Descriptive statistical methods were used to evaluate data. In addition, a logistic regression analysis was performed to identify the influential factors in the presence of polypharmacy. The results were evaluated at a significance level of p<0.05. Results: The prevalence of polypharmacy was 24.1%. In addition, 51.6%, 52.1%, and 12.1% older adults used at least one over-thecounter drug, herbal medicines along with prescribed medications, and alternative treatment methods, respectively. However, older patients with four or more chronic diseases were exposed to polypharmacy approximately nine times (95% confidence interval 3.02-26.75) more than those with 1-3 chronic diseases. Conclusion: Approximately one-quarter of the older adults had polypharmacy, which was affected by multiple variables. The older adults should be evaluated for prescription and non-prescription drug use, and the rational drug use education should be provided.
Keywords: Geriatrics; cross-sectional studies; polypharmacy
Amaç: Bu çalışma, kırsal kesimde yaşayan yaşlılarda polifarmasi prevalansını ve ilişkili faktörleri belirlemek amacıyla gerçekleştirildi. Gereç ve Yöntemler: Bu kesitsel çalışmaya Türkiye'nin batısında bir ilçede yaşayan 65 yaş ve üzeri toplam 585 yaşlı dâhil edildi. Veriler literatür doğrultusunda araştırmacılar tarafından hazırlanan anket formu aracılığı ile aile sağlığı merkezlerinde yüz yüze görüşme yöntemiyle toplandı. Araştırma için toplanan veriler, Windows 25.0 için SPSS kullanılarak analiz edildi. Verilerin değerlendirilmesinde tanımlayıcı istatistiksel yöntemler kullanıldı. Ayrıca polifarmasi varlığında etkili olan faktörleri belirlemek için lojistik regresyon analizi yapıldı. Sonuçlar p<0,05 anlamlılık düzeyinde değerlendirildi. Bulgular: Bu çalışmada, polifarmasi prevalansı %24,1 olarak belirlendi. Ayrıca yaşlıların reçeteli ilaçlarla birlikte sırasıyla %51,6, %52,1 ve %12,1'inin en az bir reçetesiz ilaç, bitkisel ilaç ve alternatif tedavi yöntemlerini kullandıkları görüldü. Bununla birlikte, 4 veya daha fazla kronik hastalığı olan yaşlıların, 1-3 kronik hastalığı olanlara göre yaklaşık 9 kat (%95 güven aralığı 3,02-26,75) daha fazla polifarmasiye maruz kaldığı belirlendi. Sonuç: Yaşlıların yaklaşık 1/4'ünde polifarmasi durumunun mevcut olduğu ve bazı değişkenlerin polifarmasi ile ilişkili olduğu görüldü. Bu bağlamda, yaşlıların reçeteli ve reçetesiz ilaç kullanımı açısından değerlendirilmesi ve akılcı ilaç kullanımı konusunda eğitilmesi önerilebilir.
Anahtar Kelimeler: Geriatri; kesitsel çalışma; polifarmasi
- Dagli RJ, Sharma A. Polypharmacy: a global risk factor for elderly people. J Int Oral Health. 2014;6(6):i-ii. [PubMed] [PMC]
- Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. [Crossref] [PubMed] [PMC]
- Hughes C. Appropriate and inappropriate polypharmacy-Choosing the right strategy. Br J Clin Pharmacol. 2021;87(1):84-6. [Crossref] [PubMed]
- Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21(2):181-7. [Crossref] [PubMed]
- World Health Organization. Medication Safety in Polypharmacy: Technical Report [e-book]. Geneva: World Health Organization; 2019. [Link]
- Hsu HF, Chen KM, Belcastro F, Chen YF. Polypharmacy and pattern of medication use in community-dwelling older adults: a systematic review. J Clin Nurs. 2021;30(7-8):918-28. [Crossref] [PubMed]
- Aydos TR, Emre Aydıngöz S, Lux KM, Efe OE, İşli F, Aksoy M, et al. Polypharmacy prevalence among geriatric patients in primary healthcare settings across Turkey: a cross-sectional analysis through the nationwide prescription information system. Turkish Journal of Geriatrics. 2020;23(2):169-79. [Crossref]
- Mehta RS, Kochar BD, Kennelty K, Ernst ME, Chan AT. Emerging approaches to polypharmacy among older adults. Nature Aging. 2021;1:347-56. [Crossref]
- Cadenas R, Diez MJ, Fernández N, García JJ, Sahagún AM, Sierra M, et al. Prevalence and associated factors of polypharmacy in nursing home residents: a cross-sectional study. Int J Environ Res Public Health. 2021;18(4):2037. [Crossref] [PubMed] [PMC]
- Spekalski MVDS, Cabral LPA, Grden CRB, Bordin D, Bobato GR, Krum EA. Prevalence and factors associated to polypharmacy in older adults from a rural area. Revista Brasileira de Geriatria e Gerontologia. 2021;24(4):e210151. [Crossref]
- Midão L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213-20. [Crossref] [PubMed]
- Slater N, White S, Venables R, Frisher M. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA). BMJ Open. 2018;8(3):e020270. [Crossref] [PubMed] [PMC]
- Cho HJ, Chae J, Yoon SH, Kim DS. Aging and the prevalence of polypharmacy and hyper-polypharmacy among older adults in south korea: a national retrospective study during 2010-2019. Front Pharmacol. 2022;13:866318. [Crossref] [PubMed] [PMC]
- Eltaher SM, Araby EM. Prevalence and factors associated with polypharmacy among elderly persons. The Egyptian Journal of Community Medicine. 2019;37(3):55-61. [Crossref]
- Gokce Kutsal Y, Barak A, Atalay A, Baydar T, Kucukoglu S, Tuncer T, et al. Polypharmacy in the elderly: a multicenter study. J Am Med Dir Assoc. 2009;10(7):486-90. [Crossref] [PubMed]
- Bahat G, Tufan F, Bahat Z, Tufan A, Aydin Y, Akpinar TS, et al. Comorbidities, polypharmacy, functionality and nutritional status in Turkish community-dwelling female elderly. Aging Clin Exp Res. 2014;26(3):255-9. [Crossref] [PubMed]
- Küçükdağlı P. Polypharmacy and related factors in geriatric outpatients. Eur J Geriatric Gerontol. 2019;1:56-60. [Crossref]
- Seixas BV, Freitas GR. Polypharmacy among older Brazilians: prevalence, factors associated, and sociodemographic disparities (ELSI-Brazil). Pharm Pract (Granada). 2021;19(1):2168. [Crossref] [PubMed] [PMC]
- Castioni J, Marques-Vidal P, Abolhassani N, Vollenweider P, Waeber G. Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study. BMC Health Serv Res. 2017;17(1):840. [Crossref] [PubMed] [PMC]
- Lande RG, Gragnani C. Relationships between polypharmacy and the sleep cycle among active-duty service members. J Am Osteopath Assoc. 2015;115(6):370-5. [Crossref] [PubMed]
- Kim J, Lee M, Dan H. Gender differences in factors affecting life satisfaction of the elderly with multimorbidity in Korea. Nurs Rep. 2021;11(1):54-63. [Crossref] [PubMed] [PMC]
- Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging. 2009;26(6):493-503. [Crossref] [PubMed]
- Abe T, Tamiya N, Kitahara T, Tokuda Y. Polypharmacy as a risk factor for hospital admission among ambulance-transported old-old patients. Acute Med Surg. 2015;3(2):107-13. [Crossref] [PubMed] [PMC]
- Cadogan CA, Ryan C, Hughes CM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Saf. 2016;39(2):109-16. [Crossref] [PubMed] [PMC]
- Carvalho MF, Romano-Lieber NS, Bergsten-Mendes G, Secoli SR, Ribeiro E, Lebrão ML, et al. Polypharmacy among the elderly in the city of São Paulo, Brazil - SABE Study. Rev Bras Epidemiol. 2012;15(4):817-27. English, Portuguese. [Crossref] [PubMed]
.: Process List